Rigel Pharmaceuticals Inc (RIGL)
Stock-Based Compensation
$16.41M
TTM · Period ending: · USD

RIGL Stock-Based Compensation
Latest reported$16.41Mperiod ending
Latest reported$16.41Mperiod ending
RIGL TTM Stock-Based Comp ($3.72M → $16.41M)
TTM stock-based compensation
High-resolution chart · PNG
RIGL stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 16,411,000 | |
| 12,843,000 | |
| 12,711,000 | |
| 12,050,000 | |
| 11,331,000 | |
| 10,583,000 | |
| 12,393,000 | |
| 12,239,000 | |
| 11,538,000 | |
| 11,182,000 | |
| 8,806,000 | |
| 10,953,000 | |
| 11,717,000 | |
| 11,936,000 | |
| 12,385,000 | |
| 10,644,000 | |
| 10,139,000 | |
| 10,054,000 | |
| 9,486,000 | |
| 8,779,000 | |
| 8,461,000 | |
| 7,912,000 | |
| 7,297,000 | |
| 7,076,000 | |
| 7,290,000 | |
| 8,186,000 | |
| 9,115,000 | |
| 9,761,000 | |
| 10,658,000 | |
| 9,117,000 | |
| 7,704,000 | |
| 8,706,000 | |
| 6,584,000 | |
| 6,572,000 | |
| 5,987,000 | |
| 5,594,000 | |
| 5,936,000 | |
| 6,850,000 | |
| 7,333,000 | |
| 6,292,000 | |
| 6,892,000 | |
| 6,787,000 | |
| 7,403,000 | |
| 8,989,000 | |
| 9,254,000 | |
| 9,477,000 | |
| 9,787,000 | |
| 8,139,000 | |
| 8,122,000 | |
| 7,737,000 | |
| 7,166,000 | |
| 8,866,000 | |
| 10,048,000 | |
| 11,312,000 | |
| 12,617,000 | |
| 12,395,000 | |
| 12,240,000 | |
| 12,429,000 | |
| 13,168,000 | |
| 13,928,000 | |
| 14,605,000 | |
| 15,106,000 | |
| 16,436,000 | |
| 16,416,000 | |
| 16,181,000 | |
| 16,339,000 | |
| 13,438,000 | |
| 9,657,000 | |
| 6,125,000 | |
| 2,266,000 | |
| 5,846,000 | |
| 5,846,000 | |
| 5,846,000 | |
| 5,846,000 | |
| 2,622,000 | |
| 15,201,000 | |
| 15,201,000 | |
| 15,201,000 | |
| 16,140,000 | |
| 3,591,000 | |
| 3,591,000 | |
| 3,591,000 | |
| 36,000 | |
| 133,000 | |
| 133,000 | |
| -677,000 | |
| -629,000 | |
| -756,000 | |
| -756,000 | |
| -236,000 | |
| -66,000 | |
| -66,000 | |
| -66,000 | |
| 224,000 | |
| 480,000 | |
| 3,113,000 | |
| 3,113,000 | |
| 3,113,000 | |
| 3,722,000 |